Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報

  • CRID
    1573387450387035136
  • NII論文ID
    10021293574
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ